![Louis Tamayo](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Patrimonio netto: 383 706 $ in data 31/07/2026
Louis Tamayo is Chief Financial Officer at Lexeo Therapeutics, Inc. since 2025.
Formerly, Mr. Tamayo was Senior Vice President – Operational Excellence at Siemens Healthineers AG from 2023 to 2024.
Education includes an undergraduate degree from Northeastern University.
| Società | Data | Numero di azioni | Valutazione | Data di valutazione |
|---|---|---|---|---|
| 18/08/2026 | 92.907 ( 0,12% ) | 383 706 $ | 31/07/2026 |
| Società | Posizione | Inizio |
|---|---|---|
| LEXEO THERAPEUTICS, INC. | Direttore Finanziario/CFO | 15/08/2025 |
| Società | Posizione | Fine |
|---|---|---|
| SIEMENS HEALTHINEERS AG | Corporate Officer/Principal | 01/10/2024 |
Attive
Inattive
Società nel listino
Aziende private
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
| Aziende private | 3 |
|---|---|
Northeastern University
 Northeastern University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Siemens Healthineers AG
 Siemens Healthineers AG Medical SpecialtiesHealth Technology Provides diagnostic imaging and computer related services | Health Technology |
Lexeo Therapeutics Inc
 Lexeo Therapeutics Inc BiotechnologyHealth Technology Develops gene therapy to treat genetic diseases | Health Technology |
Seleziona la tua edizione
Tutte le informazioni finanziarie adattate in base al livello nazionale
